Natricarb 7.5 Injection, a prescription drug, is manufactured in various forms such as Injection. Nausea and Vomiting are some of its major therapeutic uses.
Medical history of the patient along with age and gender determines the dosage of Natricarb 7.5 Injection. The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Natricarb 7.5 Injection have been listed ahead. These side effects of Natricarb 7.5 Injection are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Natricarb 7.5 Injection has a Safe effect for pregnant women and Mild effect on lactating mothers. In addition, Natricarb 7.5 Injection's effects on the liver, heart and kidney are discussed below in the Natricarb 7.5 Injection related warnings section.
Natricarb 7.5 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Heart Disease, Calcium Deficiency, Potassium Deficiency are examples of such conditions. The section on Natricarb 7.5 Injection contraindications lists all such conditions.
Drug interactions for Natricarb 7.5 Injection have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Natricarb 7.5 Injection is considered not safe while driving, and is not addictive.
Natricarb 7.5 Injection is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Based on research, the following side effects have been observed when Natricarb 7.5 Injection is used -
Moderate
Mild
Is the use of Natricarb 7.5 Injection safe for pregnant women?
There are no side effects of Natricarb in pregnant women.
Is the use of Natricarb 7.5 Injection safe during breastfeeding?
Natricarb may have very limited harmful effects for breastfeeding women.
What is the effect of Natricarb 7.5 Injection on the Kidneys?
There are no side effects of Natricarb on the kidneys.
What is the effect of Natricarb 7.5 Injection on the Liver?
There may be an adverse effect on the liver after taking Natricarb. If you observe any side effects on your body then stop taking this drug. Take this medicine again only if your doctor advises you to do so.
What is the effect of Natricarb 7.5 Injection on the Heart?
You may experience side effects on your heart after taking Natricarb. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Natricarb 7.5 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Natricarb 7.5 Injection unless your doctor advises you to do so -
Is this Natricarb 7.5 Injection habit forming or addictive?
Natricarb 7.5 Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Natricarb 7.5 Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Natricarb 7.5 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Natricarb 7.5 Injection for mental disorders.
Interaction between Food and Natricarb 7.5 Injection
Taking Natricarb 7.5 Injection with food does not cause any problems.
Interaction between Alcohol and Natricarb 7.5 Injection
Taking Natricarb 7.5 Injection with alcohol can have severely harmful effects on your health.
It is not recommended that you discontinue taking Natricarb on your own. Discontinuing Natricarb may lead to unwanted side effects of chemotherapy and radiation therapy such as excessive vomiting. You must speak to your doctor first as this will help you to take an informed decision.
Natricarb must be taken for as long as it is prescribed by your doctor. You must not take more or less of it as it may cause side effects or disease relapse.
Yes, Natricarb is usually administered before and after surgery for treating post-anesthesia shivering (PAS) and nausea. PAS is a condition in which tremors of head, neck, trunk, shoulder, and extremities. It greatly reduces the quality of life of a patient since it causes discomfort and increases pain. It disturbs surgical care and increases the stress on cardiopulmonary functions. Hence as a precautionary measure, this medicine is administered to prevent unpleasant anesthetic effects.
No, Natricarb is not found to be effective against motion sickness. It prevents vomiting due to chemotherapeutic drugs and radiation. Motion sickness is the disturbance of the inner ear caused by a lot of motion. It can be prevented by not taking too much food or too many drinks or alcohol just before the travel. One should also avoid food with very strong odours. One should avoid reading while traveling. One should also sit in the direction of the travel. One should sit in the front. Open a vent of fresh air and try to be relaxed while traveling.
Natricarb belongs to a class of compounds known as 5 -HT3 receptor antagonists. It blocks the action of serotonin completely at the 5-HT3 receptor sites present in our brain (vomiting centre) which provides relief to the patient from nausea and vomiting.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 947-948
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 668
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran (ondansetron hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Zofran® (ondansetron hydrochloride)
